Telepharmacy Robotic Medicine Delivery Unit "TRMDU" Assessment
Primary Purpose
Traumatic Brain Injury, Posttraumatic Stress Disorders, Trauma
Status
Withdrawn
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
TMRDU
Sponsored by
About this trial
This is an interventional health services research trial for Traumatic Brain Injury focused on measuring Telepharmacy Robotic Medicine Delivery Unit, Brain Injuries, Stress Disorders, Combat disorders, Polytrauma, Adherence
Eligibility Criteria
Inclusion Criteria: Subjects must be
- At least 18 years of age
- Alert and oriented to person , place and time
- Primarily use English language for written and oral communication
- Have diagnosis of Traumatic Brain Injury(TBI) Multiple Traumatic Brain Injury (MTBI), Post Traumatic Stress Disorder (PTSD) or Polytrauma.
- Taking at least 4 chronic prescription medications
- Living in a participating WTU or enrolled in Tampa Veterans Administration polytrauma outpatient treatment facility at the time of enrollment
- Achieve a minimum score of 24 on Mini-Mental State Examination
Exclusion Criteria: If patients meet following criteria they are excluded from the study
- Disabilities preventing safe use of the TRMDU
- Projected life expectancy of less than 3 months
Sites / Locations
- Naval Hospital Camp Pendleton
- James A Haley VA Hospital and Polytrauma Facility
- Ireland Army Community Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
TMRDU
Control
Arm Description
Telepharmacy Robotic Medicine Delivery Unit (TMRDU) group will receive TMRDU plus medication management
Control arm will receive only medication management, no TMRDU.
Outcomes
Primary Outcome Measures
Adherence
Pill counts and self report (Morisky 8-item)
Secondary Outcome Measures
Intensity and type of pain
Short-Form McGill Pain Questionnaire; 15 descriptors rated on intensity of 0=none to 3=severe
Psychological well-being
Profile of Moods Brief Scale; scores of 6 subscales range from 0-20, with higher scores indicating higher distress, except for one subscale which is negatively scored.
Health related quality of life
Short-Form 36; 8 domains of general health with higher scores indicating less disability
Total cost of care
Six-month medication and medical cost of care will be extracted from the DOD prescription and medical claims databases
Full Information
NCT ID
NCT01007006
First Posted
November 2, 2009
Last Updated
July 24, 2019
Sponsor
University of Illinois at Chicago
Collaborators
U.S. Army Medical Research and Development Command
1. Study Identification
Unique Protocol Identification Number
NCT01007006
Brief Title
Telepharmacy Robotic Medicine Delivery Unit "TRMDU" Assessment
Official Title
Evaluation of a Telepharmacy Robotic Medicine Delivery Unit in Warrior Transition Unit Patients With Traumatic Brain Injury, Post-Traumatic Stress Disorder, or Polytrauma
Study Type
Interventional
2. Study Status
Record Verification Date
July 2019
Overall Recruitment Status
Withdrawn
Why Stopped
Unable to gain approval from commanding Army and Navy officers to conduct study.
Study Start Date
December 2010 (Anticipated)
Primary Completion Date
December 2011 (Anticipated)
Study Completion Date
December 2011 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Illinois at Chicago
Collaborators
U.S. Army Medical Research and Development Command
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The objective of this study is to evaluate whether use of TRMDU in addition to medication review leads to improved outcomes and reduced health care costs for patients when compared with medication review alone. The study will be conducted in patients assigned to Department of Defense (DOD) Warrior Transition Units (WTU's), similar DOD units, and VA polytrauma centers.
Detailed Description
The military has been witnessing an increased number of patients with combat related impairments such as traumatic brain injury, post traumatic stress disorder and polytrauma which has lead to sub optimal medication self management. TRMDU is a medical device developed by INRange Systems Inc. that delivers medications and emits a sound alert to assist the patient. It can be used in a hospital, clinic, or residential setting. It can be remotely accessed by the health care professionals, and it allows physicians and other prescribers to remotely change scheduling or adjust prescriptions.
Use of TRMDU in hospital settings is expected to improve outcomes by improving medication self management, increasing adherence, reducing medication errors, and thereby associated costs. Further, it may contribute to overall improvement in a patient's psychological well-being and quality of life.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Traumatic Brain Injury, Posttraumatic Stress Disorders, Trauma, Combat Disorders, Pain
Keywords
Telepharmacy Robotic Medicine Delivery Unit, Brain Injuries, Stress Disorders, Combat disorders, Polytrauma, Adherence
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
TMRDU
Arm Type
Experimental
Arm Description
Telepharmacy Robotic Medicine Delivery Unit (TMRDU) group will receive TMRDU plus medication management
Arm Title
Control
Arm Type
No Intervention
Arm Description
Control arm will receive only medication management, no TMRDU.
Intervention Type
Device
Intervention Name(s)
TMRDU
Other Intervention Name(s)
Electronic Medication Management Assistant, (EMMA) (R)
Intervention Description
The TMRDU will assist study subjects with taking their medications as prescribed by notifying them when the next dose is due and tracking whether and when it was taken.
Primary Outcome Measure Information:
Title
Adherence
Description
Pill counts and self report (Morisky 8-item)
Time Frame
Six months
Secondary Outcome Measure Information:
Title
Intensity and type of pain
Description
Short-Form McGill Pain Questionnaire; 15 descriptors rated on intensity of 0=none to 3=severe
Time Frame
Three months
Title
Psychological well-being
Description
Profile of Moods Brief Scale; scores of 6 subscales range from 0-20, with higher scores indicating higher distress, except for one subscale which is negatively scored.
Time Frame
Three months
Title
Health related quality of life
Description
Short-Form 36; 8 domains of general health with higher scores indicating less disability
Time Frame
Three months
Title
Total cost of care
Description
Six-month medication and medical cost of care will be extracted from the DOD prescription and medical claims databases
Time Frame
Six months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Subjects must be
At least 18 years of age
Alert and oriented to person , place and time
Primarily use English language for written and oral communication
Have diagnosis of Traumatic Brain Injury(TBI) Multiple Traumatic Brain Injury (MTBI), Post Traumatic Stress Disorder (PTSD) or Polytrauma.
Taking at least 4 chronic prescription medications
Living in a participating WTU or enrolled in Tampa Veterans Administration polytrauma outpatient treatment facility at the time of enrollment
Achieve a minimum score of 24 on Mini-Mental State Examination
Exclusion Criteria: If patients meet following criteria they are excluded from the study
Disabilities preventing safe use of the TRMDU
Projected life expectancy of less than 3 months
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Daniel R Touchette, MA
Organizational Affiliation
University of Illinois at Chicago
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jill M Winters, PhD
Organizational Affiliation
Columbia College of Nursing
Official's Role
Principal Investigator
Facility Information:
Facility Name
Naval Hospital Camp Pendleton
City
Camp Pendleton
State/Province
California
ZIP/Postal Code
92055
Country
United States
Facility Name
James A Haley VA Hospital and Polytrauma Facility
City
Tampa
State/Province
Florida
ZIP/Postal Code
33613
Country
United States
Facility Name
Ireland Army Community Hospital
City
Fort Knox
State/Province
Kentucky
ZIP/Postal Code
40121
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
17617512
Citation
Bates DW. Preventing medication errors: a summary. Am J Health Syst Pharm. 2007 Jul 15;64(14 Suppl 9):S3-9; quiz S24-6. doi: 10.2146/ajhp070190. Erratum In: Am J Health Syst Pharm. 2007 Aug 15;64(16):1678.
Results Reference
background
PubMed Identifier
18219234
Citation
Cantor JB, Ashman T, Gordon W, Ginsberg A, Engmann C, Egan M, Spielman L, Dijkers M, Flanagan S. Fatigue after traumatic brain injury and its impact on participation and quality of life. J Head Trauma Rehabil. 2008 Jan-Feb;23(1):41-51. doi: 10.1097/01.HTR.0000308720.70288.af.
Results Reference
background
PubMed Identifier
11297331
Citation
Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash). 2001 Mar-Apr;41(2):192-9. doi: 10.1016/s1086-5802(16)31229-3.
Results Reference
background
PubMed Identifier
1202204
Citation
Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189-98. doi: 10.1016/0022-3956(75)90026-6. No abstract available.
Results Reference
background
PubMed Identifier
15229303
Citation
Hoge CW, Castro CA, Messer SC, McGurk D, Cotting DI, Koffman RL. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N Engl J Med. 2004 Jul 1;351(1):13-22. doi: 10.1056/NEJMoa040603.
Results Reference
background
Citation
Institute for Healthcare Improvement. (2009). Prevent adverse drug events (medication reconciliation).
Results Reference
background
PubMed Identifier
19146365
Citation
Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care. 2009 Jan;15(1):59-66.
Results Reference
background
PubMed Identifier
17101639
Citation
Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006 Dec 6;296(21):2563-71. doi: 10.1001/jama.296.21.joc60162. Epub 2006 Nov 13.
Results Reference
background
PubMed Identifier
12472329
Citation
McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002 Dec 11;288(22):2868-79. doi: 10.1001/jama.288.22.2868. Erratum In: JAMA. 2003 Jun 25;289(24):3242.
Results Reference
background
PubMed Identifier
3670870
Citation
Melzack R. The short-form McGill Pain Questionnaire. Pain. 1987 Aug;30(2):191-197. doi: 10.1016/0304-3959(87)91074-8.
Results Reference
background
PubMed Identifier
18453793
Citation
Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008 May;10(5):348-54. doi: 10.1111/j.1751-7176.2008.07572.x.
Results Reference
background
PubMed Identifier
10439982
Citation
Nathan A, Goodyer L, Lovejoy A, Rashid A. 'Brown bag' medication reviews as a means of optimizing patients' use of medication and of identifying potential clinical problems. Fam Pract. 1999 Jun;16(3):278-82. doi: 10.1093/fampra/16.3.278.
Results Reference
background
PubMed Identifier
17000934
Citation
O'Connor PJ. Improving medication adherence: challenges for physicians, payers, and policy makers. Arch Intern Med. 2006 Sep 25;166(17):1802-4. doi: 10.1001/archinte.166.17.1802. No abstract available.
Results Reference
background
PubMed Identifier
16079372
Citation
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005 Aug 4;353(5):487-97. doi: 10.1056/NEJMra050100. No abstract available.
Results Reference
background
PubMed Identifier
19366872
Citation
Sakthong P, Chabunthom R, Charoenvisuthiwongs R. Psychometric properties of the Thai version of the 8-item Morisky Medication Adherence Scale in patients with type 2 diabetes. Ann Pharmacother. 2009 May;43(5):950-7. doi: 10.1345/aph.1L453. Epub 2009 Apr 14.
Results Reference
background
PubMed Identifier
14528539
Citation
Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999 Jun;37(2):113-24. doi: 10.1016/s0738-3991(98)00107-4.
Results Reference
background
PubMed Identifier
17176683
Citation
Touchette DR, Burns AL, Bough MA, Blackburn JC. Survey of medication therapy management programs under Medicare part D. J Am Pharm Assoc (2003). 2006 Nov-Dec;46(6):683-91. doi: 10.1331/1544-3191.46.6.683.touchette.
Results Reference
background
PubMed Identifier
15054145
Citation
van Mil JW, Westerlund LO, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother. 2004 May;38(5):859-67. doi: 10.1345/aph.1D182. Epub 2004 Mar 30.
Results Reference
background
PubMed Identifier
16882958
Citation
Vasterling JJ, Proctor SP, Amoroso P, Kane R, Heeren T, White RF. Neuropsychological outcomes of army personnel following deployment to the Iraq war. JAMA. 2006 Aug 2;296(5):519-29. doi: 10.1001/jama.296.5.519.
Results Reference
background
Citation
Institute for Healthcare Improvement. (2009).
Results Reference
background
PubMed Identifier
14562485
Citation
Burkhart PV, Sabate E. Adherence to long-term therapies: evidence for action. J Nurs Scholarsh. 2003;35(3):207. No abstract available.
Results Reference
background
Citation
McNair, D., M. Lorr, et al. (1992). POMS Manual
Results Reference
background
Citation
National Council on Patient Information and Education. (2008).
Results Reference
background
Citation
Ware, J. E., K. K. Snow, et al. (1993). SF36 health survey: Manual and interpretation guide. Boston. MA, New England Medical Center
Results Reference
background
Links:
URL
http://www.ihi.org/IHI/Programs/Campaign/ADEsMedReconciliation.htm
Description
Institute for healthcare improvement "Preventing adverse drug events" Retrieved June 22, 2009
URL
http://www.talkaboutrx.org/documents/enhancing_prescription_medicine_adherence.pdf
Description
National Council on Patient Information and Education. (2008). "Public policy & adherence." Retrieved July 20, 2008
Learn more about this trial
Telepharmacy Robotic Medicine Delivery Unit "TRMDU" Assessment
We'll reach out to this number within 24 hrs